Mitochondrial Metabolite Detection for Concussion Severity Assessment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current diagnostic methods for evaluating the severity of concussions and mild traumatic brain injuries are inadequate, particularly for non-medical personnel, as they lack accuracy and reliability, and fail to predict potential long-term damage, due to the blood-brain barrier's limitations and the complexity of cellular, biochemical, and neurological factors involved.
Innovation Solution
Development of a diagnostic system using computer-readable devices with affixed bioreagents, such as monoclonal antibodies and mitochondrial releasates, to analyze mitochondrial metabolites and damage-associated molecular patterns in blood samples, providing a predictive indicator of neuronal injury severity and susceptibility to long-term brain damage.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If traditional evaluation methods (Glasgow Coma Score) are used by non-medical personnel, then ease of operation is improved, but measurement precision and reliability deteriorate
Solution Approach 1:
The patent replaces subjective mechanical evaluation (visual observation and questioning by coaches/trainers) with an automated biochemical detection system. The handheld device uses bioreagents to detect mitochondrial metabolites in saliva or blood samples, providing objective quantitative data that eliminates human subjectivity while remaining simple to operate.
Solution Approach 2:
The patent introduces mitochondrial metabolites as intermediary biomarkers that mediate between the complex neurological damage and the simple detection process. These metabolites serve as reliable indicators of brain injury severity, allowing non-medical personnel to obtain accurate measurements through simple sample collection without needing to understand complex neurological assessment.
2Measurement precision
If comprehensive neurological evaluation is performed by specialists, then measurement precision is improved, but loss of time and productivity deteriorate
Solution Approach 1:
The patent extracts the essential diagnostic function from complex neurological evaluation by focusing specifically on mitochondrial metabolite detection. This extraction allows the critical assessment function to be performed rapidly by non-specialists using a simple device, while eliminating the need for time-consuming comprehensive neurological exams by specialists in most cases.
Solution Approach 2:
The patent performs preliminary biochemical assessment immediately at the site of injury using the handheld device. This preliminary action provides rapid triage information that can immediately guide decisions about whether further specialized neurological evaluation is needed, significantly reducing the time loss associated with waiting for specialist assessment.
3Reliability
If blood-brain barrier limitations are considered, then reliability of traditional methods deteriorates, but device complexity increases to overcome this barrier
Solution Approach 1:
The patent uses disposable bioreagent cartridges or strips that are pre-loaded with specific antibodies or enzymes designed to detect mitochondrial metabolites. These single-use components eliminate the need for complex sample preparation and handling equipment, providing reliable detection while keeping the overall device simple and affordable.
4Ease of operation
If subjective best guess appraisal is used by coaches, then ease of operation is improved, but reliability and measurement precision deteriorate
Solution Approach 1:
The patent enables the evaluation system to serve itself by using objective biochemical data to automatically determine concussion severity and return-to-play recommendations. The device processes the sample and provides interpretable results without requiring the operator (coach or trainer) to make subjective judgments, thereby maintaining ease of operation while dramatically improving reliability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This system enables rapid, reliable assessment of concussion severity and potential long-term brain damage, allowing for informed decisions on medical attention and preventing permanent brain damage, even in non-medical settings like athletic fields and emergency responses.
Implementation Method 1
diagnostic bioreagents (such as monoclonal antibodies, single-stranded DNA or RNA, etc.) which are affixed to surfaces of computer-readable devices
Data Source
AI summary
Methods and materials are disclosed for evaluating head brain injuries that do not involve blood loss or skull fractures, such as possible concussions. These methods and materials involve bioreagents (such as monoclonal antibodies, single-stranded DNA or RNA, etc.) affixed to computer-readable devices handled by electronic readers that can interact with portable computers (such as laptops, pads or tablets, smart phones, etc.). The bioreagents will detect the presence and concentration of at least two metabolites that are released by mitochondria in response to cellular damage. Additional bioreagents may be included, for detecting and quantifying other damage-associated molecular patterns (DAMP's). When used along with cognitive, reasoning, and/or response tests, this type of analysis can help non-physicians assess the severity of, and proper responses to, head traumas that otherwise are difficult or impossible to reliably evaluate.